Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
17,672,584
-
Shares change
-
+981,184
-
Total reported value, excl. options
-
$384,025,414
-
Value change
-
+$23,406,418
-
Put/Call ratio
-
0%
-
Number of buys
-
51
-
Number of sells
-
38
-
Price
-
$21.73
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q3 2025
As of 30 Sep 2025 Eton Pharmaceuticals, Inc. - Common Stock (ETON) had 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,672,584 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., EcoR1 Capital, LLC, BlackRock, Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, Westside Investment Management, Inc., and CANNELL CAPITAL LLC.
This table shows 114 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.